Heart transplantation: Assessment of heart failure mortality risk

Current Heart Failure Reports

Volumn 4, Issue 2, 2007, Pages 103-109

  Matthews, Jennifer Cowger ^b   Dardas, Todd F ^b   Aaronson, Keith D ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEART FAILURE; HEART TRANSPLANTATION; HOSPITAL PATIENT; HUMAN; MORTALITY; OUTPATIENT; REVIEW; RISK ASSESSMENT;

HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; RISK ASSESSMENT; RISK FACTORS;

EID: 34250766576     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-007-0008-3     Document Type: Review

References (26)

1. American Heart Association: Heart Disease and Stroke Facts, 2006 Update. Dallas: American Heart Association; 2006.
2. US Department of Health and Human Services, National Center for Health Statistics, National Hospital Discharge Survey, 2004 [computer file]. Hyattsville: US Department of Health and Human Services, National Center for Health Statistics; 2006.
3. Rose EA, Gelijns AC, Moskowitz AJ, et al.: Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. (REMATCH) study group. Long-term use of a left ventricular assist device for end stage heart failure. N Engl J Med 2001, 345:1435-1443.
4. Cohn JN, Tognoni G, Valsartan Heart Failure Trial Investigators: A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001, 345:1667-1675.
5. Eichhorn E: Prognostic determination in heart failure. Am J Med 2001, 110:14S-35S.
6. • Fonarow GC, Adams KF, Abraham WT, et al.: Risk stratification for in-hospital mortality in acutely decompensated heart failure. Classification and regression tree analysis. JAMA 2005, 293:572-580. Risk stratification tree generated from the ADHERE database for predicting in-hospital mortality in patients with systolic and diastolic HF.
7. Rohde LE, Goldraich L, Polanczyk CA, et al.: A simple clinically based predictive rule for heart failure in-hospital mortality. J Card Fail 2006, 12:587-593.
8. Lee DS, Austin PC, Rouleau JL, et al.: Predicting mortality among patients hospitalized for heart failure. Derivation and validation of a clinical model. JAMA 2003, 290:2581-2587.
9. Aaronson KD, Schawrtz JS, Chen TM, et al.: Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997, 95:2660-2667.
10. •• Levy WC, Mozaffarian D, Linker DT, et al.: The Seattle heart failure model. Prediction of survival in heart failure. Circulation 2006, 113:1424-1433. Derivation and validation of the SHFM for predicting 1-, 2-, and 3-year survival in outpatients with systolic and diastolic heart failure.
11. American Heart Association: Heart Disease and Stroke Statistics - 2006 Update. Dallas: American Heart Association; 2006.
12. Baker DW, Chin MH, Cinquegrani AF: ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. J Am Coll Cardiol 2001, 38:2101-2113.
13. Taylor DO, Edwards LB, Boucek MM, et al.: Registry for the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report - 2005. J Heart Lung Transplant 2005, 24:945-955.
14. Levy D, Kenchaiah S, Larson MG, et al.: Long term trends in the incidence of and survival with heart failure. N Engl J Med 2002, 347:1397-1402.
15. Corra U, Mezzani A, Bosimini E, Giannuzzi P: Cardiopulmonary exercise testing and prognosis in chronic heart failure: a prognosticating algorithm for the individual patient. Chest 2004, 126:942-950.
16. Clark AL: Exercise and heart failure: assessment and treatment. Heart 2006, 92:699-703.
17. Mancini DM, Eisen H, Kussmaul W et al.: Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991, 83:778-786.
18. Stelken AM, Younis LT, Jennison SH, et al.: Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol 1996, 27:345-352.
19. Osman AF, Mehra MR, Lavie CJ, et al.: The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol 2000, 36:2126-2131.
20. Chua TP, Ponikowski P, Harrington D, et al.: Clinical correlates and prognostic significance of the ventilatory response to exercise in CHF. J Am Coll Cardiol 1997, 29:1585-1590.
21. Pohwani AL, Murali S, Matheir MM, et al.: Impact of β-blocker therapy on functional capacity criteria for heart transplant listing. J Heart Lung Transplant 2003, 22:78-86.
22. • Koelling TM, Joseph S, Aaronson KD: Heart Failure Survival Score continues to predict clinical outcomes in patients with heart failure receiving β-blockers. J Heart Lung Transplant 2004, 23:1414-1422. Evaluation of the HFSS in a group of patients on contemporary medical therapies and assessment of the impact of β-blocker therapy on the HFSS.
23. • Butler J, Khadim G, Paul KM, et al.: Selection of patients for heart transplantation in the current era of heart failure therapy. J Am Coll Cardiol 2004, 43:787-793. Reevaluation of the HFSS in patients on contemporary HF therapy, demonstrating the impact of β-blocker therapies on HFSS prognostication.
24. Packer M, O'Connor CM, Ghali JK, et al.: Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996, 335:1107-1114.
25. 2 assessment in HF risk stratification.
26. • Lietz K, Long J, Kfoury G, et al.: Risk score to predict survival to hospital discharge after left-ventricular assist device (LVAD) implantation as destination therapy (DT) [abstract 010]. J Card Fail 2006, 12(Suppl 1):S4. Risk prediction score for predicting survival in candidates selected for LVAD placement as destination therapy.